Kabivec 4Mg/4Ml Inj belongs to the class of neuromuscular blocking agents. It is mainly used as an adjuvant to general anaesthesia to aid in endotracheal intubation and to give skeletal muscle relaxation during surgery or mechanical breathing.
Kabivec 4Mg/4Ml Inj contains Vecuronium bromide. It relaxes the muscles by blocking the impulses from the nerves.
Kabivec 4Mg/4Ml Inj will be administered only in a hospital setting by an experienced clinician or an anaesthetist. This medicine could occasionally have undesirable side effects, such as skeletal muscle weakness, prolonged skeletal muscle paralysis, respiration insufficiency or apnea, and bronchospasm/respiratory depression. Your doctor will immediately address these issues if they emerge during your procedure.
Kabivec 4Mg/4Ml Inj is not recommended for patients known to be hypersensitive to it. Kabivec 4Mg/4Ml Inj should be used in pregnant women only if clinically needed, and the benefits outweigh the risks. So, inform your doctor before receiving Kabivec 4Mg/4Ml Inj if you are pregnant or planning for pregnancy. So, tell your doctor about your medical conditions, sensitivities, and prescriptions. Breastfeeding should be stopped for a certain period after Kabivec 4Mg/4Ml Inj is administered, as per the doctor's direction. The safety and effectiveness of Kabivec 4Mg/4Ml Inj in pediatric patients under seven weeks of age have not been established. After receiving, patients should not drive or operate heavy machinery for at least 24 hours.